Rigel Pharmaceuticals
RIGL
#6163
Rank
C$1.22 B
Marketcap
C$67.63
Share price
3.25%
Change (1 day)
106.39%
Change (1 year)

Rigel Pharmaceuticals (RIGL) - Total debt

Total debt on the balance sheet as of September 2025 : C$84.16 Million

According to Rigel Pharmaceuticals's latest financial reports the company's total debt is C$84.16 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Rigel Pharmaceuticals - Total debt on balance sheet (from 2000 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$86.04 M7.09%
2023-12-31C$80.34 M42.5%
2022-12-31C$56.38 M44.75%
2021-12-31C$38.95 M-21.84%
2020-12-31C$49.83 M5.09%
2019-12-31C$47.42 M
2018-12-31N/A
2011-12-31N/A-100%
2010-12-31C$0.79 M-60.9%
2009-12-31C$2.04 M-50.4%
2008-12-31C$4.12 M133.05%
2007-12-31C$1.76 M-35.35%
2006-12-31C$2.73 M6.77%
2005-12-31C$2.56 M1.54%
2004-12-31C$2.52 M-44.31%
2003-12-31C$4.53 M-49.65%
2002-12-31C$9 M-23.76%
2001-12-31C$11.81 M-13.49%
2000-12-31C$13.65 M23.68%
1999-12-31C$11.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ChemoCentryx
CCXI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$35.14 M-58.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$45.11 B 53,500.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Amgen
AMGN
C$75.46 B 89,563.27%๐Ÿ‡บ๐Ÿ‡ธ USA